(19)
(11) EP 4 536 360 A1

(12)

(43) Date of publication:
16.04.2025 Bulletin 2025/16

(21) Application number: 23732121.1

(22) Date of filing: 12.06.2023
(51) International Patent Classification (IPC): 
A61P 35/00(2006.01)
A61K 31/277(2006.01)
 C07C 255/44(2006.01)
(52) Cooperative Patent Classification (CPC):
C07C 255/44; A61K 31/519; A61K 45/06; A61K 31/609; A61P 35/00
 
C-Sets:
  1. A61K 31/519, A61K 2300/00;
  2. A61K 31/609, A61K 2300/00;
(86) International application number:
PCT/EP2023/065619
(87) International publication number:
WO 2023/242106 (21.12.2023 Gazette 2023/51)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 13.06.2022 EP 22020274

(71) Applicant: KHR Biotec GmbH
21037 Hamburg (DE)

(72) Inventor:
  • RAJALINGAM, Krishnaraj
    55268 Nieder-Olm (DE)

(74) Representative: Zellentin & Partner mbB Patentanwälte 
Rubensstraße 30
67061 Ludwigshafen
67061 Ludwigshafen (DE)

   


(54) NOVEL RAS INHIBITORS